Tissue Repair (ASX:TRP) Common Stock: A$35.04 Mil (As of Dec. 2025)


ASX:TRP Tissue Repair Ltd ASX:TRP
29 GF Score
Price A$0.12
View Full Analysis

What is Tissue Repair Common Stock?

Tissue Repair ASX:TRP +20.00% 29 Common Stock is A$35.04 Mil as of Dec. 2025. GuruFocus rates ASX:TRP with a GF Score™ of 29/100.

Tissue Repair's quarterly common stock stayed the same from Dec. 2024 (A$35.04 Mil) to Jun. 2025 (A$35.04 Mil) and stayed the same from Jun. 2025 (A$35.04 Mil) to Dec. 2025 (A$35.04 Mil).

Tissue Repair's annual common stock stayed the same from Jun. 2023 (A$35.04 Mil) to Jun. 2024 (A$35.04 Mil) and stayed the same from Jun. 2024 (A$35.04 Mil) to Jun. 2025 (A$35.04 Mil).

Tissue Repair Common Stock Historical Data

* Premium members only.

The historical data trend for Tissue Repair's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tissue Repair Common Stock Chart

Tissue Repair Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
33.06 35.04 35.04 35.04 35.04

Tissue Repair Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.04 35.04 35.04 35.04 35.04
ASX:TRP
29GF Score
Tissue Repair Ltd ASX:TRP
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tissue Repair Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$35.04 Mil mean?
Tissue Repair (ASX:TRP) has a Common Stock of A$35.04 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Tissue Repair and its competitors.
Is Tissue Repair's Common Stock too high?
Tissue Repair's current Common Stock is A$35.04 Mil. Overall, Tissue Repair has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Tissue Repair's Common Stock compare to VRTX and REGN?
Tissue Repair's Common Stock of A$35.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Tissue Repair and its competitors. Tissue Repair's current Common Stock is A$35.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tissue Repair stock overvalued right now?
Tissue Repair (ASX:TRP) has a current Common Stock of A$35.04 Mil. The current Common Stock is A$35.04 Mil. Tissue Repair's overall GF Score™ is 29/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Tissue Repair (ASX:TRP), the current Common Stock is A$35.04 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tissue Repair Business Description

Address 821 Pacific Highway, Tower A, Level 9, The Zenith, Chatswood, NSW, AUS, 2067
Tissue Repair Ltd is a clinical-stage biopharmaceutical company engaged in development of wound healing products for chronic wounds and the aftercare of cosmetic procedures, with the potential for further development of related technologies.
29GF Score

Get the complete analysis for ASX:TRP

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.12
Price